Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HET Bipolar System: Validation of a New Minimally Invasive Outpatient Treatment for Symptomatic Hemorrhoids

NCT02773420 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT02773420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02773420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HET Bipolar System: Validation of a New Minimally Invasive Outpatient Treatment for Symptomatic Hemorrhoids
Lead sponsor
University of Illinois at Chicago
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2015
Completion date
January 31, 2019
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhoids